全文获取类型
收费全文 | 104649篇 |
免费 | 8695篇 |
国内免费 | 6129篇 |
专业分类
耳鼻咽喉 | 1114篇 |
儿科学 | 1545篇 |
妇产科学 | 2304篇 |
基础医学 | 12385篇 |
口腔科学 | 1951篇 |
临床医学 | 14007篇 |
内科学 | 16587篇 |
皮肤病学 | 894篇 |
神经病学 | 5671篇 |
特种医学 | 3529篇 |
外国民族医学 | 42篇 |
外科学 | 11234篇 |
综合类 | 14799篇 |
现状与发展 | 23篇 |
一般理论 | 20篇 |
预防医学 | 6116篇 |
眼科学 | 2864篇 |
药学 | 10707篇 |
56篇 | |
中国医学 | 4821篇 |
肿瘤学 | 8804篇 |
出版年
2024年 | 277篇 |
2023年 | 1504篇 |
2022年 | 3804篇 |
2021年 | 4945篇 |
2020年 | 3512篇 |
2019年 | 3227篇 |
2018年 | 3545篇 |
2017年 | 2925篇 |
2016年 | 2843篇 |
2015年 | 4408篇 |
2014年 | 5619篇 |
2013年 | 5007篇 |
2012年 | 7527篇 |
2011年 | 8265篇 |
2010年 | 4976篇 |
2009年 | 3815篇 |
2008年 | 5273篇 |
2007年 | 5525篇 |
2006年 | 5409篇 |
2005年 | 5700篇 |
2004年 | 3833篇 |
2003年 | 3398篇 |
2002年 | 3005篇 |
2001年 | 2442篇 |
2000年 | 2650篇 |
1999年 | 2703篇 |
1998年 | 1578篇 |
1997年 | 1481篇 |
1996年 | 1308篇 |
1995年 | 1161篇 |
1994年 | 982篇 |
1993年 | 635篇 |
1992年 | 998篇 |
1991年 | 805篇 |
1990年 | 684篇 |
1989年 | 600篇 |
1988年 | 593篇 |
1987年 | 529篇 |
1986年 | 420篇 |
1985年 | 330篇 |
1984年 | 208篇 |
1983年 | 159篇 |
1982年 | 85篇 |
1981年 | 98篇 |
1980年 | 83篇 |
1979年 | 115篇 |
1978年 | 54篇 |
1977年 | 56篇 |
1975年 | 44篇 |
1974年 | 45篇 |
排序方式: 共有10000条查询结果,搜索用时 10 毫秒
991.
992.
PURPOSE: We examined the efficacy of potassium citrate based medical prophylaxis for preventing upper urinary calculous recurrence, and compared it with the stone recurrence rate in patients who only received intermittent or no medical prophylaxis. MATERIALS AND METHODS: We retrospectively reviewed the records of 493 patients with upper urinary calculi, of whom 237 men and 76 women with a mean age of 56.1 and 51.4 years, respectively, were enrolled in the study. Of the 313 participants 64 (group 1, 20.4%) received regular medical prophylaxis for 24 to 42 months (mean 27.8), 80 (group 2, 25.6%) received intermittent medical prophylaxis for 1.5 to 19 months (mean 7.9) and 169 (group 3, 54%) did not receive any medical prophylaxis. RESULTS: At midterm followup of 24 to 60 months 107 patients (34.2%) had stone recurrence. In group 1 the stone recurrence rate was 7.8%, which was significantly less (p <0.001) than in groups 2 (30%) and 3 (46.2%). Similarly new calculous events in patients with a history of multiple stone recurrence were less frequent in group 1 than in groups 2 and 3 (9.7, 47.4 and 52.2%, respectively, p <0.001). Multiple stone recurrence history, hypercalciuria, hyperuricosuria and calcium oxalate dihydrate calculi were independent risk factors for stone recurrence. CONCLUSIONS: Regular medical prophylaxis may effectively prevent stone recurrence regardless of previous treatment modalities, stone composition, metabolic abnormalities and stone-free status. Cost effectiveness, patient compliance and gastrointestinal upset may limit patient acceptability and clinical use of medical prophylaxis. However, patients with a history of multiple stone recurrence, calcium oxalate dihydrate stones, hypercalciuria and hyperuricosuria benefit from regular medical prophylaxis. 相似文献
993.
994.
995.
Beta-hexosaminidase (Hex) is a lysosomal enzyme that exists as two isoenzymes: Hex A (subunit structure alphabeta) and Hex B (betabeta). Its presence in the testis and epididymis suggests important roles for Hex and its substrates in male fertility and reproductive functions. Disruption of the Hexa gene encoding the alpha-subunit of Hex has led to the generation of a mildly affected mouse model of human Tay-Sachs disease, allowing us the opportunity to analyze the effects of isolated Hex A deficiency on epithelial cellular morphology of the male reproductive tract. At 5 weeks and at 3, 5, and 12 months, the testes, efferent ducts and epididymides of Hex A-deficient (Hexa -/-) and wild-type (Hexa +/+) mice were perfuse fixed and analyzed by routine light and electron microscopy as well as with immunocytochemistry employing antibodies to lysosomal enzymes. In the testis, the seminiferous epithelium of Hexa -/- mice appeared comparable to that of wild-type mice in appearance and topographical arrangement of its cell types at all ages examined. Also, no differences were noted for the efferent ducts. In contrast, there were striking abnormalities in the epididymides of the mutant mice; however, the abnormalities were mainly restricted to the initial segment and intermediate zone. Principal cells of these regions at 5 weeks showed a dramatic increase in the number of lysosomes as compared with those from wild-type animals, and this progressed with increasing age. Furthermore, unlike the few small lysosomes present in wild-type mice, those of Hexa -/- mice were at times enlarged and often filled the supranuclear and basal regions of these cells. In the light microscope, large, dense cellular aggregates were noted at the base of the epithelium in the proximal initial segment that corresponded in the electron microscope to two different cell types, both of which increased in size with age. One aggregate was considered to belong to narrow cells on the basis of the presence of numerous cup-shaped vesicles characteristic of these cells; they appeared to be dislocated from the upper half of the epithelium. In the distal initial segment and intermediate zone, narrow cells were readily identified, but rather than being slender as in the control animals, they were greatly enlarged and filled with pale lysosomes in mutant mice. The second type of cellular aggregate noted in the proximal initial segment corresponded to halo cells. They contained numerous small and large lysosomes and small, Golgi-related, dense, core granules characteristic of halo cells. On the basis of the large size of these cells, they appeared to be actively internalizing substances from the intercellular space. In contrast, principal and clear cells of the caput, corpus, and cauda regions did not appear to show a significant increase in number or size of lysosomes as compared with those of wild-type animals. All structures identified as lysosomes in the various cell types were immunoreactive for cathepsin D. The present data thus reveal that isolated Hex A deficiency results in region- and cell-specific abnormalities in the epididymis but in no apparent abnormalities in the testis or efferent ducts. Specific roles for Hex A that cannot be compensated for by other isozymes of Hex appear to exist within lysosomes of epithelial cells predominantly of the initial segment and intermediate zone. Taken together, the results also suggest that the inability to degrade endocytosed substrates normally acted upon by Hex A in lysosomes of principal and narrow cells leads to their accumulation, eventual fusion, and increased size. 相似文献
996.
997.
肉毒碱治疗TPN大鼠肝脂肪变性的研究 总被引:4,自引:1,他引:3
目的 探讨在全胃肠外营养(TPN)中补充肉毒碱减轻肝脂肪变性的作用。方法 18只正常Wistar大鼠和19只肝硬化Wistar大鼠分别随机分为6组,A1组、A2组,自由进食和进水(各6只);B1组、B2组,TPN(分别6只、7只);C1组、 ,TPN加肉毒碱(各6只)。各组实验结束后测肝功能,肝脂肪及行肝脏的组织学检查。结果 TPN组肝内脂肪显著2,TPN+肉毒碱组肝内脂肪明显减少。结论 在TPN 相似文献
998.
重组人神经营养因子-4/5蛋白抗三氧化二砷神经毒作用 总被引:5,自引:0,他引:5
目的初步观察重组人神经营养因子-4/5(hNT-4/5)蛋白对三氧化二砷毒性的抑制作用。方法利用hNT-4/5蛋白具有抗神经毒性的特点,采用本实验室克隆表达及部分纯化的具有天然hNT-4/5蛋白生物学活性的重组hNT-4/5蛋白,以不同水平的重组hNT4/5蛋白(0-100μl)与不同浓度的As2O3(0-160μmol/L)同时加入各组鸡胚前脑神经细胞和PC12细胞培养液中共同孵育24-48小时,观察其对染毒鸡胚前脑神经细胞存活和PC12细胞突起生长的影响作用。结果在鸡胚前脑神经细胞和PC12细胞中与As2O3共同培养48小时后,对照组与实验组的细胞存活率差异有显著性,而且细胞存活率和突起数目随hNT-4/5浓度增高而提高和增加。结论初步观察到重组hNT4/5蛋白具有抑制As2O3的毒性作用,为从基因工程途径寻找抗环境毒物因子提供了依据。 相似文献
999.
OBJECTIVE: To describe the time trend of mortality rates of cerebrovascular diseases (CVD) in Hong Kong for the period of 1976 to 1995, and to compare them with those in the more developed countries around the world. METHODS: Mortality rates of CVD were standardized directly using world standard population in 1961. Annual percent changes of mortality rates of CVD were estimated with a non-linear regression. Birth-cohort analysis was carried out at an interval of five-year of age to compare their age-specific mortality rates of CVD in different birth cohorts. Time trend of cause-specific mortality rates of CVD both in males and females was fitted with a simple linear regression model. RESULTS: Considerable downward trend of CVD mortality was observed during the past twenty years. Mortality rates among men and women decreased by 50.96% and 37.85% in 1995, as compared to those in 1976, respectively. Although in general, a greater trend in CVD mortality was observed during the last 10 years, as compared with that in the previous 10 years, an annual increase in CVD mortality of 1.34% was found among males aged 35 to 44 years during the latter 10 years. CVD mortality for both males and females decreased steadily by 1% per year. CVD mortality for females will catch up with that for males by the year of 2013, if such a trend continues. Birth-cohort analysis showed that those born more recently at the same age-group had lower mortality of CVD (except for those born after 1955). Data from hospital admission showed that improvement in the treatment for CVD could have contributed partly to the decrease in its mortality. CONCLUSION: Time trend of mortality of CVD in Hong Kong was similar to that in many other economically developed areas around the world. 相似文献
1000.
L Wang J A Huang H S Nagesha S C Smith A Phelps I Holmes J C Martyn P J Coloe P R Reeves 《Vaccine》1999,17(20-21):2636-2645
The outer capsid protein of rotavirus, VP7, is a major neutralization antigen. A chimeric protein comprising Escherichia coli (E. coli) outer membrane protein A (OmpA) and part of porcine rotavirus VP7 containing all three antigenic regions (217 amino acids) was expressed in Salmonella and E. coli as an outer-membrane associated protein. Mice immunized intraperitoneally or orally, respectively, with live E. coli or Salmonella cells expressing this chimeric protein produced antibodies against native VP7 as determined by enzyme-linked immunosorbent assays and neutralization tests. This indicates that the VP7 fragment from a porcine rotavirus which is antigenically similar to human rotavirus serotype 3, when expressed in bacteria as a chimeric protein, can form a structure resembling its native form at least in some of the major neutralization domains. These results indicate that the use of a live bacterial vector expressing rotavirus VP7 may represent a strategy for the development of vaccines against rotavirus-induced diarrhoea in infants. 相似文献